Bharat Biotech commences Covaxin exports
Hyderabad: Hyderabad-based Covid-19 vaccine (Covaxin) maker Bharat Biotech on Monday said the company has commenced the exports of the vaccine. “Long pending export orders have been executed during November, to be further expanded during the following months. With the number of countries that have granted emergency use approvals for Covaxin increasing, exports to additional countries […]
Updated On - 29 November 2021, 02:25 PM
Hyderabad: Hyderabad-based Covid-19 vaccine (Covaxin) maker Bharat Biotech on Monday said the company has commenced the exports of the vaccine.
“Long pending export orders have been executed during November, to be further expanded during the following months. With the number of countries that have granted emergency use approvals for Covaxin increasing, exports to additional countries will also commence from December,” the company stated.
Thanking the Government of India for approving exports, the company added, “Covaxin will now become an integral part of the global fight against this pandemic.”
Meanwhile, in a separate statement, the Ministry of Health and Family Welfare said the country’s cumulative Covid-19 vaccination coverage exceeded 122.41 crore.
Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.
Click to follow Telangana Today Facebook page and Twitter .